Active Shortage

MIDAZOLAM INJECTION USP

PFIZER CANADA ULC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of MIDAZOLAM INJECTION USP in Canada?

Yes. MIDAZOLAM INJECTION USP 5MG has an active shortage reported to Health Canada (last updated November 5, 2026).

Why is MIDAZOLAM INJECTION USP not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will MIDAZOLAM INJECTION USP be available again?

No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusActive Shortage

Same-ingredient products on file3 products · 2 same form & route

Affected strength5MG

Report last updated2026-11-05

Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

MIDAZOLAM INJECTION

SANDOZ CANADA INCORPORATED

5MG · DIN 02240286

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

Other Products

MIDAZOLAM INJECTION, USP

FRESENIUS KABI CANADA LTD

1MG · DIN 02242904

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

BUCCOLAM

NEURAXPHARM PHARMACEUTICALS, S.L.

2.5MG · DIN 02559579

Different strengthSame dosage formDifferent routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

This product is usually given in a hospital or clinic, where the pharmacy team manages supply. If you're scheduled to receive it, ask your care team.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02382350

Strength

5MG

Dosage Form

SOLUTION

Route

INTRAVENOUS INTRAMUSCULAR

Active Ingredient

MIDAZOLAM

Tier

Unrated

Last Updated

2026-11-05

Reason for Shortage

Disruption of the manufacture of the drug.

Source

View original report on healthproductshortages.ca ↗

Past Reports for This Drug

MIDAZOLAM INJECTION USP has 2 shortage/discontinuation reports on file — this is one of them.

2026-11-05

Active Shortage

Disruption of the manufacture of the drug.

Other Products from PFIZER CANADA ULC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

40MG · DIN 02511053

40MG · DIN 02511045

20MG · DIN 02511061

DIN 02544040

5MG · DIN 01947664

10MG · DIN 01947672